TY - JOUR
T1 - Symmetric and asymmetric receptor conformation continuum induced by a new insulin
AU - Xiong, Xiaochun
AU - Blakely, Alan
AU - Kim, Jin Hwan
AU - Menting, John G.
AU - Schäfer, Ingmar B.
AU - Schubert, Heidi L.
AU - Agrawal, Rahul
AU - Gutmann, Theresia
AU - Delaine, Carlie
AU - Zhang, Yi Wolf
AU - Artik, Gizem Olay
AU - Merriman, Allanah
AU - Eckert, Debbie
AU - Lawrence, Michael C.
AU - Coskun, Ünal
AU - Fisher, Simon J.
AU - Forbes, Briony E.
AU - Safavi-Hemami, Helena
AU - Hill, Christopher P.
AU - Chou, Danny Hung Chieh
N1 - Publisher Copyright:
© 2022, The Author(s), under exclusive licence to Springer Nature America, Inc.
PY - 2022/5
Y1 - 2022/5
N2 - Cone snail venoms contain a wide variety of bioactive peptides, including insulin-like molecules with distinct structural features, binding modes and biochemical properties. Here, we report an active humanized cone snail venom insulin with an elongated A chain and a truncated B chain, and use cryo-electron microscopy (cryo-EM) and protein engineering to elucidate its interactions with the human insulin receptor (IR) ectodomain. We reveal how an extended A chain can compensate for deletion of B-chain residues, which are essential for activity of human insulin but also compromise therapeutic utility by delaying dissolution from the site of subcutaneous injection. This finding suggests approaches to developing improved therapeutic insulins. Curiously, the receptor displays a continuum of conformations from the symmetric state to a highly asymmetric low-abundance structure that displays coordination of a single humanized venom insulin using elements from both of the previously characterized site 1 and site 2 interactions. [Figure not available: see fulltext.]
AB - Cone snail venoms contain a wide variety of bioactive peptides, including insulin-like molecules with distinct structural features, binding modes and biochemical properties. Here, we report an active humanized cone snail venom insulin with an elongated A chain and a truncated B chain, and use cryo-electron microscopy (cryo-EM) and protein engineering to elucidate its interactions with the human insulin receptor (IR) ectodomain. We reveal how an extended A chain can compensate for deletion of B-chain residues, which are essential for activity of human insulin but also compromise therapeutic utility by delaying dissolution from the site of subcutaneous injection. This finding suggests approaches to developing improved therapeutic insulins. Curiously, the receptor displays a continuum of conformations from the symmetric state to a highly asymmetric low-abundance structure that displays coordination of a single humanized venom insulin using elements from both of the previously characterized site 1 and site 2 interactions. [Figure not available: see fulltext.]
UR - http://www.scopus.com/inward/record.url?scp=85126205351&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85126205351&partnerID=8YFLogxK
U2 - 10.1038/s41589-022-00981-0
DO - 10.1038/s41589-022-00981-0
M3 - Article
C2 - 35289328
AN - SCOPUS:85126205351
SN - 1552-4450
VL - 18
SP - 511
EP - 519
JO - Nature Chemical Biology
JF - Nature Chemical Biology
IS - 5
ER -